BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

879 related articles for article (PubMed ID: 35488243)

  • 1. Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies.
    Lu Y; Yuan X; Wang M; He Z; Li H; Wang J; Li Q
    J Hematol Oncol; 2022 Apr; 15(1):47. PubMed ID: 35488243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Gut Microbiota-Derived Metabolites on Immune Checkpoint Inhibitor Therapy: Enemy or Friend?
    Zhao H; Wang D; Zhang Z; Xian J; Bai X
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome in modulating immune checkpoint inhibitors.
    Li X; Zhang S; Guo G; Han J; Yu J
    EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
    Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
    Front Immunol; 2021; 12():669150. PubMed ID: 34267748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiome bacterial influencers of host immunity and response to immunotherapy.
    Yousefi Y; Baines KJ; Maleki Vareki S
    Cell Rep Med; 2024 Apr; 5(4):101487. PubMed ID: 38547865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
    Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
    Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer.
    Hayase E; Jenq RR
    Genome Med; 2021 Jun; 13(1):107. PubMed ID: 34162429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment.
    Xu H; Cao C; Ren Y; Weng S; Liu L; Guo C; Wang L; Han X; Ren J; Liu Z
    Front Immunol; 2022; 13():949490. PubMed ID: 36177041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality.
    Guillot N; Roméo B; Manesh SS; Milano G; Brest P; Zitvogel L; Hofman P; Mograbi B
    Trends Mol Med; 2023 Nov; 29(11):897-911. PubMed ID: 37704493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers.
    McQuade JL; Ologun GO; Arora R; Wargo JA
    Curr Oncol Rep; 2020 Jun; 22(7):74. PubMed ID: 32577835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
    Lau HCH; Sung JJ; Yu J
    Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Species of Gut Bacteria Associated with Antitumor Immunity in Cancer Therapy.
    Qi X; Liu Y; Hussein S; Choi G; Kimchi ET; Staveley-O'Carroll KF; Li G
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal microbiota transplantation: no longer cinderella in tumour immunotherapy.
    Yang Y; An Y; Dong Y; Chu Q; Wei J; Wang B; Cao H
    EBioMedicine; 2024 Feb; 100():104967. PubMed ID: 38241975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes.
    Ting NL; Lau HC; Yu J
    Gut; 2022 Jul; 71(7):1412-1425. PubMed ID: 35277453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses.
    Wang W; Fan J; Zhang C; Huang Y; Chen Y; Fu S; Wu J
    Microbiol Res; 2024 May; 282():127668. PubMed ID: 38430889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut Microbiota in Cancer Immune Response and Immunotherapy.
    Zhou CB; Zhou YL; Fang JY
    Trends Cancer; 2021 Jul; 7(7):647-660. PubMed ID: 33674230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
    Hou X; Zheng Z; Wei J; Zhao L
    Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut Microbiota and Antitumor Immunity: Potential Mechanisms for Clinical Effect.
    Baruch EN; Wang J; Wargo JA
    Cancer Immunol Res; 2021 Apr; 9(4):365-370. PubMed ID: 34003768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The triple interactions between gut microbiota, mycobiota and host immunity.
    Yang J; Yang H; Li Y
    Crit Rev Food Sci Nutr; 2023 Nov; 63(33):11604-11624. PubMed ID: 35776086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complex interactions between the microbiome and cancer immune therapy.
    Schwartz DJ; Rebeck ON; Dantas G
    Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.